gabexate has been researched along with Colitis, Ulcerative in 2 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Colitis, Ulcerative: Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishise, S | 1 |
| Takeda, Y | 1 |
| Fujishima, S | 1 |
| Orii, T | 1 |
| Sato, T | 1 |
| Sasaki, Y | 1 |
| Nishise, Y | 1 |
| Takeda, H | 1 |
| Kawata, S | 1 |
| Senda, S | 1 |
| Fujiyama, Y | 1 |
| Bamba, T | 1 |
| Hosoda, S | 1 |
2 other studies available for gabexate and Colitis, Ulcerative
| Article | Year |
|---|---|
Release of interleukin-1 receptor antagonist by combining a leukocyte adsorption carrier with ulinastatin.
Topics: Adsorption; Blood Component Removal; Cellulose; Colitis, Ulcerative; Dose-Response Relationship, Dru | 2010 |
Treatment of ulcerative colitis with camostat mesilate, a serine protease inhibitor.
Topics: Adult; Colitis, Ulcerative; Esters; Gabexate; Guanidines; Humans; Male; Serine Proteinase Inhibitors | 1993 |